We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cryo-Save | LSE:CRYO | London | Ordinary Share | NL0009272137 | ORD EUR0.10 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 420.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/9/2008 09:50 | a 150k buy goes thru' at 70p (= 105000 pounds) | andrbea | |
24/9/2008 09:35 | they were growing revenues at 70% a year in June (year on year) so a growth industry... and good European coverage from 165p just a month ago, the fall in share price is way overdone IMO (just delays) and new markets to break into soon (France & India) I've bought some this week. A no-brainer IMO | andrbea | |
23/9/2008 21:57 | On the face of it this looks to becoming a major player in the stem cell market, recent price fall is giving more consideration to buyers poised to purchase, as the current drop stirs up interest. It may still come off a tad more, but dont be surprised if it bounces back to former heights as it enters into the french stem cell storage and marketing zone the furture is fast becoming stem cell and its still early days for the roll out across world markets. vision88 Inspecting current progress | vision88 | |
14/5/2008 11:03 | lots of news on stem cell research with debate in Parliament this week. could be one to watch. | norman the doorman | |
14/5/2008 10:59 | Cryo-Save Group's vision is to become the industry's global centre of excellence in the application and intellectual development of cryo-technology of human tissues and stem cells. Cryo-Save Group strives to be a global healthcare provider in the field of tissue engineering and stem cell therapeutic applications. Cryo-Save Group believes that many future treatments of patients will be based upon stem cell therapies scientifically tested and developed and prescribed by specialists in hospitals. In order to embrace this evolution, the company has started to preserve the required materials, e.g. stem cells. To develop this vision, the company intends to expand geographically its European leadership of family stem cell banking towards other regions and ultimately towards other continents. In August 2006 the company became active in the Middle East through its partnership with Cryo-Save Arabia, the region's first family cord blood stem cell bank at the Dubai Biotechnology and Research Park. Furthermore, Cryo-Save Group is investing its human and capital resources in the research and development of expansion of human tissues and cells and in the potential therapeutic applications. Ultimately and for that purpose the company's mission is to establish strategic partnerships and synergies with both public and private organisations and institutes driven by the same scientific approach in order to realise this common vision. | norman the doorman | |
07/11/2007 16:28 | commands 50% of the market and entering china and india where health care lags behind -- so freezing umbilical cord stemcells would seem to be a brilliant idea A stem cell is not just for xmas its for life !! How about that for marketing slogan ! | bigboyo |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions